Method for qualitative and quantitative multiplexing of drug analytes from biological samples
A method for qualitative and quantitative multiplexing of drug analytes from dried blood samples includes the steps of mixing an Internal Standard solution with a first diluent in a vessel, adding the dried blood sample to the vessel, sonicating the vessel containing the Internal Standard solution, the first diluent and the dried blood sample, removing the dried blood sample from the vessel so that a final sample can be attained, and analyzing at least a portion of the final sample using one of LC-MS and LC-MS/MS to simultaneously determine the presence or absence of a plurality of different analytes in the dried blood sample. The Internal Standard solution can include at least 8, 15, 25 or 50 Internal Standards. The dried blood sample is generated using less than 50 μL, 20 μL or 10 μL of blood. The step of analyzing includes simultaneously determining the presence or absence of at least 15, 60, 90 or 130 different analytes. A ratio of the number of analytes for which the presence or absence is being determined to the number of Internal Standards in the Internal Standard solution is at least approximately 2:1. A ratio of the number of analytes for which the presence or absence is being determined to the volume (in μL) of the final sample being analyzed is at least approximately 2:1. A ratio of the number of analytes for which the presence or absence is being determined to the volume (in μL) of blood from which the dried blood sample was obtained is at least approximately 4:5.
1. A method for qualitative and quantitative multiplexing of drug analytes from a dried blood sample, the method comprising the steps of:
mixing an Internal Standard solution with a first diluent in a vessel, the Internal Standard solution including a plurality of different Internal Standards;
adding the dried blood sample to the vessel;
sonicating the vessel containing the Internal Standard solution, the first diluent and the dried blood sample;
removing the dried blood sample from the vessel so that a final sample can be attained; and
analyzing at least a portion of the final sample using one of LC-MS and LC-MS/MS to simultaneously determine the presence or absence of a plurality of different analytes in the dried blood sample.
2. The method of claim 1 wherein the Internal Standard solution includes a plurality of Internal Standards.
3. The method of claim 1 wherein the Internal Standard solution includes at least 15 Internal Standards.
4. The method of claim 1 wherein the Internal Standard solution includes at least 25 Internal Standards.
5. The method of claim 1 wherein the Internal Standard solution includes at least 50 Internal Standards.
6. The method of claim 1 wherein the dried blood sample is generated using less than 50 μL of blood.
7. The method of claim 1 wherein the dried blood sample is generated using less than 20 μL of blood.
8. The method of claim 1 wherein the dried blood sample is generated using less than 10 μL of blood.
9. The method of claim 1 wherein the first diluent is methanol.
10. The method of claim 1 wherein the first diluent includes water and methanol.
11. The method of claim 10 wherein a ratio of the volume of the water to the volume of the methanol is less than 1:1.
12. The method of claim 10 wherein a ratio of the volume of the water to the volume of the methanol is approximately 1:4.
13. The method of claim 1 further comprising the step of adding a second diluent after the step of removing the dried blood sample from the vessel.
14. The method of claim 13 wherein the second diluent is water.
15. The method of claim 14 wherein the volume of the second diluent is substantially similar to the volume of the first diluent.
16. The method of claim 1 wherein the step of analyzing includes simultaneously determining the presence or absence of at least 15 different analytes.
17. The method of claim 1 wherein the step of analyzing includes simultaneously determining the presence or absence of at least 60 different analytes.
18. The method of claim 1 wherein the step of analyzing includes simultaneously determining the presence or absence of at least 90 different analytes.
19. The method of claim 1 wherein the step of analyzing includes simultaneously determining the presence or absence of at least 130 different analytes.
20. The method of claim 1 wherein the step of analyzing includes using one of LC-MS and LC-MS/MS in a positive ionization mode.
21. The method of claim 1 wherein the step of analyzing includes using one of LC-MS and LC-MS/MS in a negative ionization mode.
22. The method of claim 1 wherein a ratio of the number of analytes for which the presence or absence is being determined to the number of Internal Standards in the Internal Standard solution is at least approximately 2:1.
23. The method of claim 1 wherein a ratio of the number of analytes for which the presence or absence is being determined to the number of Internal Standards in the Internal Standard solution is at least approximately 5:1.
24. The method of claim 1 wherein a ratio of the number of analytes for which the presence or absence is being determined to the volume (in μL) of the final sample being analyzed is at least approximately 2:1.
25. The method of claim 1 wherein a ratio of the number of analytes for which the presence or absence is being determined to the volume (in μL) of the final sample being analyzed is at least approximately 5:1.
26. The method of claim 1 wherein a ratio of the number of analytes for which the presence or absence is being determined to the volume (in μL) of blood from which the dried blood sample was obtained is at least approximately 4:5.
27. A method for qualitative and quantitative multiplexing of drug analytes from a dried blood sample, the dried blood sample being obtained from not greater than 20 μL of blood, the method comprising the steps of:
mixing an Internal Standard solution with a first diluent in a vessel, the Internal Standard solution including a plurality of Internal Standards;
adding the dried blood sample to the vessel;
sonicating the vessel containing the Internal Standard solution, the first diluent and the dried blood sample;
removing the dried blood sample from the vessel so that a final sample can be attained; and
analyzing at least a portion of the final sample using one of LC-MS and LC-MS/MS to simultaneously determine the presence or absence of a plurality of different analytes in the dried blood sample; wherein a ratio of the number of analytes for which the presence or absence is being determined to the volume (in μL) of blood from which the dried blood sample was obtained is greater than approximately 3:1.
28. The method of claim 27 wherein the ratio of the number of analytes for which the presence or absence is being determined to the volume (in μL) of blood from which the dried blood sample was obtained is at least approximately 9:2.
29. The method of claim 27 wherein the ratio of the number of analytes for which the presence or absence is being determined to the volume (in μL) of blood from which the dried blood sample was obtained is at least approximately 6:1.
30. A method for qualitative and quantitative multiplexing of drug analytes from a dried blood sample, the dried blood sample being obtained from less than 20 μL of blood, the method comprising the steps of:
mixing an Internal Standard solution with a first diluent in a vessel, the Internal Standard solution including a plurality of Internal Standards;
adding the dried blood sample to the vessel;
sonicating the vessel containing the Internal Standard solution, the first diluent and the dried blood sample;
removing the dried blood sample from the vessel so that a final sample can be attained; and
analyzing at least a portion of the final sample using one of LC-MS and LC-MS/MS to simultaneously determine the presence or absence of at least 16 different analytes in the dried blood sample; wherein a ratio of the number of analytes for which the presence or absence is being determined to the volume (in μL) of blood from which the dried blood sample was obtained is greater than approximately 3:1.